Connect with us

Tech

High Growth Tech Stocks In The United States To Watch

Published

on

High Growth Tech Stocks In The United States To Watch

The United States market has remained flat over the last week, yet it is up 31% over the past year with earnings forecasted to grow by 15% annually. In this environment, identifying high growth tech stocks involves looking for companies that demonstrate strong potential for innovation and scalability while aligning with these positive market trends.

Name

Revenue Growth

Earnings Growth

Growth Rating

Super Micro Computer

23.83%

24.32%

★★★★★★

Ardelyx

25.47%

69.63%

★★★★★★

Sarepta Therapeutics

24.00%

42.51%

★★★★★★

Alnylam Pharmaceuticals

22.35%

70.33%

★★★★★★

Clene

79.31%

60.16%

★★★★★★

TG Therapeutics

34.66%

56.98%

★★★★★★

Alkami Technology

21.94%

98.60%

★★★★★★

Travere Therapeutics

31.70%

72.51%

★★★★★★

Seagen

22.57%

71.80%

★★★★★★

ImmunoGen

26.00%

45.85%

★★★★★★

Click here to see the full list of 243 stocks from our US High Growth Tech and AI Stocks screener.

Here we highlight a subset of our preferred stocks from the screener.

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Ironwood Pharmaceuticals, Inc. is a healthcare company that specializes in developing and commercializing gastrointestinal products, with a market cap of $548.90 million.

Operations: Ironwood Pharmaceuticals focuses on the development and commercialization of gastrointestinal products, generating revenue primarily from its Human Therapeutics segment, which reported $378.42 million.

Amidst a backdrop of executive reshuffles, Ironwood Pharmaceuticals has maintained its focus on growth and innovation, particularly in R&D. The company’s commitment to research is evident from its significant R&D expenditure, which is crucial for advancing its pipeline of pharmaceutical solutions. Despite recent challenges, including a notable 10% revenue growth forecast that lags behind the industry’s 20%, Ironwood has demonstrated resilience with earnings expected to surge by approximately 54.9% annually. This growth trajectory is supported by strategic moves such as the expansion of their credit facilities and active participation in major healthcare conferences, positioning them well within the competitive landscape of biotech innovations.

NasdaqGS:IRWD Earnings and Revenue Growth as at Dec 2024

Simply Wall St Growth Rating: ★★★★★☆

Overview: Lumentum Holdings Inc. is a company that manufactures and sells optical and photonic products across the Americas, Asia-Pacific, Europe, the Middle East, and Africa with a market capitalization of $6.17 billion.

Continue Reading